Results 11 to 20 of about 6,563 (147)

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan

open access: yesDermatologica Sinica, 2011
Background: Epidermal growth factor receptor antagonists, such as gefitinib, erlotinib, and cetuximab, have been used in treating carcinomas. The efficacies have been proposed to correlate with skin reactions, but the most important predictive indicator ...
Shiou-Han Wang   +7 more
doaj   +1 more source

A Rare Paronychia with Superinfection with Prevotella bivia and Staphylococcus haemolyticus: The Importance of Early Microbiological Diagnosis

open access: yesPathogens, 2020
Prevotella bivia is an anaerobic, gram-negative bacillus which naturally thrives in the human vagina, and is usually related to vaginal tract infections. However, this microorganism can also cause infections in other body locations.
Jessica Grande-Del-Arco   +4 more
doaj   +1 more source

Squareflower, Paronychia erecta

open access: yesEDIS, 2018
Squareflower is found in beach dunes, coastal grasslands, and scrub. This plant is an endemic restricted to the coastal Panhandle of Florida, counties west of the Big Bend region, and west to Louisiana.
Debbie Miller   +4 more
doaj   +5 more sources

Anaerobic paronychia

open access: yesJournal of British Surgery, 1981
Summary During 1 year 116 patients with paronychia had bacteriological cultures of the pus. Aerobic bacteria, predominantly Staphylococcus aureus were isolated from 81. Anaerobic bacteria were isolated from 35, and in 31 of these aerobes were also present.
S M, Whitehead, S J, Eykyn, I, Phillips
openaire   +2 more sources

Occupational Health Problems and Co-morbidities among Food Handlers in Kozhikode District, Kerala, India: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Over the past five years, India’s food service market has grown at 10.3%, with many people consuming food from outside. Food handlers can passively transmit infections to consumers, and occupational health problems contribute to this
Sruthikrishna Punathukandi   +4 more
doaj   +1 more source

Managing Skin Side Effects Associated With Oncology Treatments: Asian Perspective on Use of Dermocosmetics. [PDF]

open access: yesAsia Pac J Clin Oncol
Skin adverse events (AEs) frequently accompany all types of anticancer treatments. This publication discusses how recent international guidance on best‐practices use of dermocosmetics can be adapted to the North Asia region (China, Hong Kong, Japan, Republic of Korea, and Taiwan).
Pan M   +9 more
europepmc   +2 more sources

Single-stage Hallux Reconstruction with Free Wraparound Medial Plantar Artery Flap with Iliac Bone Graft: A Case Report [PDF]

open access: yesJournal of Foot and Ankle Surgery (Asia Pacific)
Hallux reconstruction remains a challenging endeavor. The main aim of reconstruction is robust soft tissue cover with minimal contour abnormality to permit normal footwear and mobility. We had a young female present with gangrenous hallux.
Raghuram Menon   +3 more
doaj   +1 more source

Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature

open access: yesDrugs in Context, 2019
Nail toxicities, such as paronychia and pyogenic granuloma-like lesions, are well-recognized side effects of epidermal growth factor receptor inhibitor (EGFR-I) therapy that can significantly impair patient’s quality of life and compliance to anticancer ...
Pietro Sollena   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy